216 related articles for article (PubMed ID: 32534258)
1. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.
Taniguchi CM; Finger EC; Krieg AJ; Wu C; Diep AN; LaGory EL; Wei K; McGinnis LM; Yuan J; Kuo CJ; Giaccia AJ
Nat Med; 2013 Oct; 19(10):1325-30. PubMed ID: 24037093
[TBL] [Abstract][Full Text] [Related]
3. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.
Yano H; Sakai M; Matsukawa T; Yagi T; Naganuma T; Mitsushima M; Iida S; Inaba Y; Inoue H; Unoki-Kubota H; Kaburagi Y; Asahara SI; Kido Y; Minami S; Kasuga M; Matsumoto M
Sci Rep; 2018 Sep; 8(1):14290. PubMed ID: 30250231
[TBL] [Abstract][Full Text] [Related]
4. A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition.
Wei K; Piecewicz SM; McGinnis LM; Taniguchi CM; Wiegand SJ; Anderson K; Chan CW; Mulligan KX; Kuo D; Yuan J; Vallon M; Morton L; Lefai E; Simon MC; Maher JJ; Mithieux G; Rajas F; Annes J; McGuinness OP; Thurston G; Giaccia AJ; Kuo CJ
Nat Med; 2013 Oct; 19(10):1331-1337. PubMed ID: 24037094
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis.
Schley G; Klanke B; Kalucka J; Schatz V; Daniel C; Mayer M; Goppelt-Struebe M; Herrmann M; Thorsteinsdottir M; Palsson R; Beneke A; Katschinski DM; Burzlaff N; Eckardt KU; Weidemann A; Jantsch J; Willam C
Kidney Int; 2019 Aug; 96(2):378-396. PubMed ID: 31146971
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation.
Lee YS; Riopel M; Cabrales P; Bandyopadhyay GK
Sci Adv; 2019 Jul; 5(7):eaaw4176. PubMed ID: 31281892
[TBL] [Abstract][Full Text] [Related]
7. Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
Sugahara M; Tanaka S; Tanaka T; Saito H; Ishimoto Y; Wakashima T; Ueda M; Fukui K; Shimizu A; Inagi R; Yamauchi T; Kadowaki T; Nangaku M
J Am Soc Nephrol; 2020 Mar; 31(3):560-577. PubMed ID: 31996409
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of oxygen-sensing prolyl hydroxylases increases lipid accumulation in human primary tubular epithelial cells without inducing ER stress.
Schley G; Grampp S; Goppelt-Struebe M
Cell Tissue Res; 2020 Jul; 381(1):125-140. PubMed ID: 32189058
[TBL] [Abstract][Full Text] [Related]
9. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.
Keely S; Campbell EL; Baird AW; Hansbro PM; Shalwitz RA; Kotsakis A; McNamee EN; Eltzschig HK; Kominsky DJ; Colgan SP
Mucosal Immunol; 2014 Jan; 7(1):114-23. PubMed ID: 23695513
[TBL] [Abstract][Full Text] [Related]
10. HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.
Ramakrishnan SK; Zhang H; Takahashi S; Centofanti B; Periyasamy S; Weisz K; Chen Z; Uhler MD; Rui L; Gonzalez FJ; Shah YM
Cell Metab; 2016 Mar; 23(3):505-16. PubMed ID: 26853750
[TBL] [Abstract][Full Text] [Related]
11. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver.
Kato S; Ochiai N; Takano H; Io F; Takayama N; Koretsune H; Kunioka EI; Uchida S; Yamamoto K
J Pharmacol Exp Ther; 2019 Dec; 371(3):675-683. PubMed ID: 31585986
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
13. Isoform-specific Roles of Prolyl Hydroxylases in the Regulation of Pancreatic β-Cell Function.
Hoang M; Jentz E; Janssen SM; Nasteska D; Cuozzo F; Hodson DJ; Tupling AR; Fong GH; Joseph JW
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34718519
[TBL] [Abstract][Full Text] [Related]
14. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity.
Choe SS; Shin KC; Ka S; Lee YK; Chun JS; Kim JB
Diabetes; 2014 Oct; 63(10):3359-71. PubMed ID: 24947359
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HIF-2α in pancreatic β cells does not alter glucose homeostasis.
Brunt JJ; Shi SY; Schroer SA; Sivasubramaniyam T; Cai EP; Woo M
Islets; 2014; 6(5-6):e1006075. PubMed ID: 25833250
[TBL] [Abstract][Full Text] [Related]
16. Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis.
Tsai YM; Wu KL; Chang YY; Chang WA; Huang YC; Jian SF; Tsai PH; Lin YS; Chong IW; Hung JY; Hsu YL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708433
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inhibits TNF-α-induced TSLP expression in keratinocytes.
Tashiro N; Segawa R; Tobita R; Asakawa S; Mizuno N; Hiratsuka M; Hirasawa N
PLoS One; 2019; 14(11):e0224705. PubMed ID: 31682627
[TBL] [Abstract][Full Text] [Related]
18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
19. The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration.
Fan L; Li J; Yu Z; Dang X; Wang K
Biomed Res Int; 2014; 2014():239356. PubMed ID: 24895555
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
Koivunen P; Serpi R; Dimova EY
Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
